Outcome of Board Meeting

Filed: 29 Sep 2026, 17:26 IST Exchange: NSE Category: Management Change — Board and KMP Restructuring

Board meeting on Sep 29, 2026 approved major management changes - Sale of 64.26% promoter shares to Indo Borax & Chemicals completed - New appointments: Suresh Kalra as MD & CEO, Sunil Malhotra and Harsh Malhotra as Executive Directors - New independent directors appointed: Amit Kumar Sharma, Anuradha Maheshwari, Dhananjay Tapasvi - New CFO appointed: Shashikant Bharuka - Resignations: MD Jogindersingh Jaswal, Executive Directors Ketan Ramani, Pritesh Ramani, CFO Samir Gadhiya, and 3 Independent Directors - Board committees reconstituted accordingly - Consultancy agreements executed with resigning promoters for transition support

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 KRONOX — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add KRONOX to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Kronox Lab Sciences Limited

Important. The summary above is generated automatically from Kronox Lab Sciences Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.